Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 64
Number Thumbnail Title Author Date Votes Views
34 Prestige Biopharma Highlights PBP1510 Clinical Progress at ASCO 2025
we******** | 2025.06.04 | Votes 0 | Views 350
we******** 2025.06.04 0 350
33 Prestige Biopharma Signs 31 European Licensing and Supply Agreement with Teva for Tuznue®
we******** | 2025.05.26 | Votes 0 | Views 274
we******** 2025.05.26 0 274
32 Prestige Biopharma Publishes Preclinical Study of Biosimilar Tuznue® in SCI Journal Drug in R&D
we******** | 2025.04.16 | Votes 0 | Views 231
we******** 2025.04.16 0 231
31 Busan-Jinhae Free Economic Zone Commissioner Visits Prestige Biopharma IDC to Discuss Biopharma Industry Collaboration
we******** | 2025.04.03 | Votes 0 | Views 169
we******** 2025.04.03 0 169
30 Prestige Biopharma to Present Preliminary Phase 1/2a Results of Pancreatic Cancer Antibody PBP1510 at AACR 2025
we******** | 2025.04.01 | Votes 0 | Views 270
we******** 2025.04.01 0 270
29 Prestige Biopharma Files Patent for Early Pancreatic Cancer Diagnostic Technology
we******** | 2025.01.22 | Votes 0 | Views 188
we******** 2025.01.22 0 188
28 Prestige Biopharma Secures Japanese Patent for Antibody Drug Candidate PBP1710 Targeting Solid Tumors
김** | 2025.01.21 | Votes 0 | Views 203
김** 2025.01.21 0 203
27 Prestige Biopharma Group Accelerates Drug Development with New R&D Hub Backed by KRW 200 Billion Investment
we******** | 2024.11.19 | Votes 0 | Views 235
we******** 2024.11.19 0 235
26 Prestige Biopharma IDC to Host First International Symposium on Emerging Biopharmaceutical Modalities
김** | 2024.11.15 | Votes 0 | Views 219
김** 2024.11.15 0 219
25 Prestige Biopharma IDC Opens New Innovative Discovery Center in Busan
김** | 2024.11.15 | Votes 0 | Views 304
김** 2024.11.15 0 304

Read Prestige news >>